VIR-2981

N/A

Report date: 2023/08/22 17:03:04

Base Information

Drug NameVIR-2981
Drug Alias NameVIR-2981
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesVir Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A